IGIBvsSBIO
iShares 5-10 Year Investment Grade Corporate Bond ETF against ALPS Medical Breakthroughs ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IGIB | SBIO | |
|---|---|---|
| Expense ratio | 0.040% | 0.50% |
| Assets | $18.6B | $114M |
| Net flow, 1 month | +$565M | — |
| Net flow, 1 year | +$3.6B | — |
| Return, YTD | -6.9% | +9.6% |
| Return, 1 year | -7.3% | +43.9% |
| Avg daily volume | 3.8M | 41K |
| Holdings | 2744 | 95 |
| Listed | Jan 5, 2007 | Dec 30, 2014 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS